Truvestments Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213 | Hold |
150
| – | – | ﹤0.01% | 922 |
|
|
2025
Q1 | $230 | Hold |
150
| – | – | ﹤0.01% | 989 |
|
|
2024
Q4 | $372 | Hold |
150
| – | – | ﹤0.01% | 962 |
|
|
2024
Q3 | $173 | Buy |
+150
| New | +$173 | ﹤0.01% | 904 |
|
|
2024
Q2 | – | Sell |
-150
| Closed | -$186 | – | 229 |
|
|
2024
Q1 | $186 | Hold |
150
| – | – | ﹤0.01% | 704 |
|
|
2023
Q4 | $158 | Hold |
150
| – | – | ﹤0.01% | 773 |
|
|
2023
Q3 | $1.03K | Hold |
150
| – | – | ﹤0.01% | 621 |
|
|
2023
Q2 | $1.56K | Hold |
150
| – | – | ﹤0.01% | 612 |
|
|
2023
Q1 | $1.21K | Sell |
150
-148
| -50% | -$1.2K | ﹤0.01% | 600 |
|
|
2022
Q4 | $4.69K | Hold |
298
| – | – | ﹤0.01% | 559 |
|
|
2022
Q3 | $5K | Hold |
298
| – | – | ﹤0.01% | 462 |
|
|
2022
Q2 | $4K | Buy |
+298
| New | +$4K | ﹤0.01% | 488 |
|
|
2022
Q1 | – | Sell |
-150
| Closed | -$2K | – | 185 |
|
|
2021
Q4 | $2K | Hold |
150
| – | – | ﹤0.01% | 541 |
|
|
2021
Q3 | $3K | Hold |
150
| – | – | ﹤0.01% | 495 |
|
|
2021
Q2 | $3K | Hold |
150
| – | – | ﹤0.01% | 501 |
|
|
2021
Q1 | $4K | Buy |
+150
| New | +$4K | ﹤0.01% | 532 |
|